2018, Controlled Substances and Patient Care

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

Controlled Substances

Patient Care

Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management

Omnicell

JANUARY 10, 2023

Tara Plappert Product Marketing Manager Hospitals and clinics face a significant challenge when dealing with controlled substances. In 2019, more than 148 million doses of medicine were lost , endangering both patients and employees. million doses were diverted in 2018, equal to the population of Arizona and California combined.

Controlled Substances

Controlled Substances Omnicell Hospitals Packaging

DEA’s Expected Guidance: It Should Reduce Current “Pain” at the (Intrathecal Pain) Pump Dispensing Process and Improve Therapeutic Outcomes

The FDA Law Blog

JUNE 23, 2024

Palmer — For more than 50 years, the Drug Enforcement Administration (DEA) has enforced the central mandate of the Controlled Substances Act (CSA) to maintain a closed chain of distribution for drugs with a potential for abuse and diversion. A qualified medical professional must perform the refill; it cannot be done by the patient.

Controlled Substances

Controlled Substances Compounding Patient Care FDA

Pharmacy Technician Pulse

Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management

DEA’s Expected Guidance: It Should Reduce Current “Pain” at the (Intrathecal Pain) Pump Dispensing Process and Improve Therapeutic Outcomes

Stay Connected